The Latest

Americans with student loans still have options. Here's what they should know.

Under 10% of surveyed wealth management professionals in a recent Arizent survey said their firms were 'very successful' at using the online networks to win clients.

The Minneapolis-based firm didn't immediately name a replacement, but pledged to maintain operations at its hybrid RIA.

An Army financial counselor defrauded loved ones of fallen soldiers for millions of dollars while breaching the rules of his position, federal prosecutors say.

Armen Meyer is chairman of the American Fintech Council board policy committee, and head of public policy and regulatory strategy at LendingClub.

A staff member in the firm's fraud investigations group found reporting failures dating back to 2009.

If at first you don't succeed, you're not alone. Here's how do it right.

Called SMArtY, the firm's free offering is slated to go live this fall with spots on a waitlist available now.

Jesse Meschuk is a career and human resources expert, and a senior adviser with Exequity.  Jesse has more than 20 years of consulting and human resources experience and has worked across a wide variety of industries including technology, entertainment, gaming, retail, hospitality, and sports. Jesse's work has spanned across the Americas, Europe and Asia.

LaRae Holliday is vice president of people for digital therapeutics leader Big Health, which is on a mission to help millions back to good mental health.

Big Health's mission is to help millions back to good mental health by providing safe and effective non-drug alternatives for the most common mental health conditions including insomnia and anxiety. Designed by leading clinical experts, Big Health's digital therapeutics expand access to gold standard care, including behavioral medicine, and are backed by industry-leading research and randomized controlled trials. By seamlessly integrating across the care pathway, from member engagement to billing via pharmacy benefit managers, Big Health simplifies adoption for both payers and patients, providing an inclusive, scalable, and affordable approach without serious side effects.